Related Experiment Video
Updated: Dec 8, 2025
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Mir-320b Inhibits Pancreatic Cancer Cell Proliferation by Targeting FOXM1
Zhou Jingyang1, Che Jinhui2, Xu Lu2
1Queen Mary School, Nanchang University, Nanchang, Jiangxi, 330027, China.
Background:
Pancreatic Ductal Adenocarcinoma (PDAC) is the most common and deadly cancer. Surgical resection is the only possible cure for pancreatic cancer but often has a poor prognosis, and the role of adjuvant therapy is urgently explored.
Methods:
MicroRNAs (miRNAs) play a very important role in tumorigenesis by regulating the target genes. In this study, we identified miR-320b lower-expressed in human pancreatic cancer tissues but relatively higher-expressed in the adjacent non-tumor tissues.
Results:
Consistently, the expression of miR-320b in different pancreatic cancer cell lines was significantly lower than the normal pancreatic cells. In order to identify the effects of miR-320b on cell growth, we overexpressed miR-320b in PANC-1 and FG pancreatic cancer cell lines, CCK8 and BrdU incorporation assay results showed that miR-320b inhibited cell proliferation.
Discussion:
We next predicted miR-320b targeted FOXM1 (Forkhead box protein M1) and identified the negative relationship between miR-320b and FOXM1. We also demonstrated that elevated miR- 320b expression inhibited tumor growth in vivo.
Conclusion:
All of these results showed that miR-320b suppressed pancreatic cancer cell proliferation by targeting FOXM1, which might provide a new diagnostic marker for pancreatic cancer.
Insights
MicroRNA-320b (miR-320b) is downregulated in pancreatic cancer. Overexpressing miR-320b inhibits tumor growth by targeting FOXM1, offering a potential diagnostic marker for pancreatic cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Pancreatic Ductal Adenocarcinoma (PDAC) is a highly lethal cancer.
- Surgical resection offers the only cure but often has a poor prognosis.
- Adjuvant therapy's role in PDAC treatment is under urgent investigation.
Purpose of the Study:
- To investigate the role of microRNAs (miRNAs) in pancreatic cancer.
- To identify specific miRNAs involved in PDAC tumorigenesis.
- To explore the potential of miR-320b as a therapeutic or diagnostic target.
Main Methods:
- Identified miR-320b expression in human pancreatic cancer tissues and cell lines.
- Overexpressed miR-320b in PANC-1 and FG pancreatic cancer cell lines.
- Utilized CCK8 and BrdU incorporation assays to assess cell proliferation.
- Predicted and validated miR-320b targets, including FOXM1.
- Evaluated the effect of elevated miR-320b on tumor growth in vivo.
Main Results:
- miR-320b expression was significantly lower in pancreatic cancer tissues and cell lines compared to normal tissues and cells.
- Overexpression of miR-320b inhibited proliferation in pancreatic cancer cell lines.
- FOXM1 was identified as a direct target of miR-320b, with an inverse relationship observed.
- Elevated miR-320b expression suppressed tumor growth in vivo.
Conclusions:
- miR-320b suppresses pancreatic cancer cell proliferation and tumor growth by targeting FOXM1.
- miR-320b may serve as a novel diagnostic marker for pancreatic cancer.
- These findings highlight miR-320b as a potential therapeutic target for PDAC.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
01:22MicroRNAs